glp-1 in type 2 diabetes GLP-1RAs Reduce External Eating Behavior with GLP-1 drugs are all approved

These foods are difficult to digest and will almost certainly trigger severe stomach cramps and explosive diarrhea while taking this medication

Serious risks & who should not take it Serious but less common risks include pancreatitis, gallbladder problems, kidney injury from dehydration, and low blood sugar (especially if combined with insulin or sulfonylureas)

As a result, Foundayo will enter the market roughly three months after Novo Nordisks Wegovy pill, intensifying competition between the two companies in the evolving GLP-1 space.

Over time, heightened reactivity to food cues in environments with abundant food can lead to weight gain or regain, disordered eating, and a decline in overall quality of life, as illustrated in Figure 5 above

However, injectable medications still face certain limitations in terms of convenience, patient adherence, and large-scale supply